AVLN
AVLN
US05348Y1055
Avalyn Pharma Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Market & Enterprise Value
Market Cap
1.14B EUR
1.46B EUR
Enterprise Value
804.93M EUR
1.21B EUR
Valuation Multiples
Trailing P/E
--
--
Forward P/E
-13.56x
--
Price to Sales
--
--
Price to Book
2.87x
3.66x
EV/Revenue
--
--
EV/EBITDA
-7.33x
--
Price to FCF (P/FCF)
--
--
EV/FCF
--
--
FCF Yield
--
-6.61%
ende